Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
  2. Davar, Diwakar; Morrison, Robert M; Dzutsev, Amiran K; Karunamurthy, Arivarasan; Chauvin, Joe-Marc; Amatore, Florent; Deutsch, Julie S; Das Neves, Rodrigo X; Rodrigues,Richard; McCulloch, John A; Wang, Hong; Hartman, Douglas J; Badger, Jonathan H; Fernandes, Miriam R; Bai, Yulong; Sun, Jie; Cole, Alicia M; Aggarwal, Poonam; Fang, Jennifer R; Deitrick, Christopher; Bao, Riyue; Duvvuri, Umamaheswar; Sridharan, Shaum S; Kim, Seungwon W; A Choudry, Haroon; Holtzman, Matthew P; Pingpank, James F; O'Toole, James Patrick; DeBlasio, Richelle; Jin, Yang; Ding, Quanquan; Gao, Wentao; Groetsch, Christopher; Pagliano, Ornella; Rose, Amy; Urban, Corey; Singh, Jagjit; Divarkar, Prajan; Mauro, David; Bobilev, Dmitri; Wooldridge, James; Krieg, Arthur M; Fury, Matthew G; Whiteaker, Jeffrey R; Zhao, Lei; Paulovich, Amanda G; Najjar, Yana G; Luke, Jason J; Kirkwood, John M; Taube, Janis M; Park, Hyun Jung; Trinchieri, Giorgio; Zarour, Hassane M
  3. Cancer Cell. 2024, Oct 30;
  1. 2.   Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models
  2. Fukushima, Hiroshi; Furusawa, Aki; Takao, Seiichiro; Thankarajan Mini Mablet,Ebaston; Luciano, Michael P; Usama, Syed Muhammad; Kano, Makoto; Okuyama, Shuhei; Yamamoto, Hiroshi; Suzuki, Motofumi; Kano, Miyu; Choyke, Peter L; Schnermann,Martin; Kobayashi, Hisataka
  3. Oncoimmunology. 2024, Jun 20; 13(1): 2370544.
  1. 3.   Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin
  2. Ruf, Benjamin; Bruhns, Matthias; Babaei, Sepideh; Kedei, Noemi; Ma, Lichun; Revsine, Mahler; Benmebarek, Mohamed-Reda; Ma, Chi; Heinrich, Bernd; Subramanyam, Varun; Qi, Jonathan; Wabitsch, Simon; Green, Benjamin L; Bauer, Kylynda C; Myojin, Yuta; Greten, Layla T; McCallen, Justin D; Huang, Patrick; Trehan, Rajiv; Wang, Xin; Nur, Amran; Murphy Soika, Dana Qiang; Pouzolles, Marie; Evans, Christine N; Chari,Raj; Kleiner, David E; Telford, William; Dadkhah, Kimia; Ruchinskas, Allison; Stovroff, Merrill K; Kang, Jiman; Oza, Kesha; Ruchirawat, Mathuros; Kroemer, Alexander; Wang, Xin Wei; Claassen, Manfred; Korangy, Firouzeh; Greten, Tim F
  3. Cell. 2023, Aug 17; 186(17): 3686-3705.e32.
  1. 4.   Robust Expansion of HIV CAR T Cells Following Antigen Boosting in ART-Suppressed Nonhuman Primates
  2. Rust, Blake J; Kean, Leslie S; Colonna, Lucrezia; Brandenstein, Katherine; Poole, Nikhita Hegde; Obenza, Willimark; Enstrom, Mark R; Maldini, Colby R; Ellis, Gavin I; Fennessey,Christine; Huang, Meei-Li; Keele, Brandon F; Jerome, Keith; Riley, James L; Kiem, Hans-Peter; Peterson, Christopher William
  3. Blood. 2020, OCT 8; 136(15): 1722-1734.
  1. 5.   Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
  2. Pérez-Guijarro, Eva; Yang, Howard H; Araya, Romina E; El Meskini,Rajaa; Michael, Helen T; Vodnala, Suman Kumar; Marie, Kerrie L; Smith,Cari; Chin, Sung; Lam, Khiem C; Thorkelsson, Andres; Iacovelli,Anthony; Kulaga,Alan; Fon, Anyen; Michalowski, Aleksandra M; Hugo, Willy; Lo, Roger S; Restifo, Nicholas P; Sharan,Shyam; Van Dyke, Terry; Goldszmid, Romina S; Ohler,Zoe; Lee, Maxwell P; Day, Chi-Ping; Merlino, Glenn
  3. Nature medicine. 2020, Apr 13;
  1. 6.   Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study
  2. Khodadoust, Michael S; Rook, Alain H; Porcu, Pierluigi; Foss, Francine; Moskowitz, Alison J; Shustov, Andrei; Shanbhag, Satish; Sokol, Lubomir; Fling, Steven P; Ramchurren, Nirasha; Pierce, Robert; Davis, Asa; Shine, Richard; Li, Shufeng; Fong, Sophia; Kim, Jinah; Yang, Yi; Blumenschein, Wendy M; Yearley, Jennifer H; Das,Biswajit; Patidar,Rajesh; Datta, Vivekananda; Cantu,Erin; McCutcheon,Justine; Karlovich,Chris; Williams,Mickey; Subrahmanyam, Priyanka B; Maecker, Holden T; Horwitz, Steven M; Sharon, Elad; Kohrt, Holbrook E; Cheever, Martin A; Kim, Youn H
  3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020, JAN 1; 38(1): 20-+.
  1. 7.   Report on the 2018 Cancer, Autoimmunity, and Immunology Conference
  2. Curran, Colleen S.; Sommers, Connie L.; Young,Howard; Bourcier, Katarzyna; Mancini, Marie; Sharon, Elad
  3. Journal of immunology (Baltimore, Md. : 1950). 2019, May 15; 202(10): 2823-2828.
  1. 8.   Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases
  2. Ranjan, Surabhi; Quezado, Martha; Garren, Nancy; Boris, Lisa; Siegel, Christine; Lopes Abath Neto, Osorio; Theeler, Brett J; Park, Deric M; Nduom, Edjah; Zaghloul, Kareem A; Gilbert, Mark R; Wu, Jing
  3. BMC Cancer. 2018, Mar 01; 18(1): 239.
  1. 9.   CTLA-4(+)PD-1(-) Memory CD4(+) T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques
  2. McGary, Colleen S; Deleage, Claire; Harper, Justin; Micci, Luca; Ribeiro, Susan P; Paganini, Sara; Kuri-Cervantes, Leticia; Benne, Clarisse; Ryan, Emily S; Balderas, Robert; Jean, Sherrie; Easley, Kirk; Marconi, Vincent; Silvestri, Guido; Estes, Jake; Sekaly, Rafick-Pierre; Paiardini, Mirko
  3. Immunity. 2017, Oct 17; 47(4): 776-788.e5.
  1. 10.   Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy
  2. Tietze, J. K.; Wilkins, D. E. C.; Sckisel, G. D.; Bouchlaka, M. N.; Alderson, K. L.; Weiss, J. M.; Ames, E.; Bruhn, K. W.; Craft, N.; Wiltrout, R. H.; Longo, D. L.; Lanier, L. L.; Blazar, B. R.; Redelman, D.; Murphy, W. J.
  3. Blood. 2012, Mar; 119(13): 3073-3083.
  1. 11.   Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model
  2. Yu, P.; Steel, J. C.; Zhang, M. L.; Morris, J. C.; Waldmann, T. A.
  3. Clinical Cancer Research. 2010, Dec; 16(24): 6019-6028.
  1. 12.   HIV-1 impairs in vitro priming of naive T cells and gives rise to contact-dependent suppressor T cells
  2. Che, K. F.; Sabado, R. L.; Shankar, E. M.; Tjomsl, V.; Messmer, D.; Bhardwaj, N.; Lifson, J. D.; Larsson, M.
  3. European Journal of Immunology. 2010, Aug; 40(8): 2248-2258.
  1. 13.   Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction
  2. Kaufmann, D. E.; Kavanagh, D. G.; Pereyra, F.; Zaunders, J. J.; Mackey, E. W.; Miura, T.; Palmer, S.; Brockman, M.; Rathod, A.; Piechocka-Trocha, A.; Baker, B.; Zhu, B.; Le Gall, S.; Waring, M. T.; Ahern, R.; Moss, K.; Kelleher, A. D.; Coffin, J. M.; Freeman, G. J.; Rosenberg, E. S.; Walker, B. D.
  3. Nature Immunology. 2007, Nov; 8(11): 1246-1254.
  1. 14.   Critical role of post-transcriptional regulation for IFN-gamma in tumor-infiltrating T cells
  2. Salerno, Fiamma; Guislain, Aurelie; Freen-Van Heeren, Julian J.; Nicolet, Benoit P.; Young,Howard; Wolkers, Monika C.
  3. Oncoimmunology. 2019 8(2):
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel